|
| |
| | | 62630 | | 12.07.2013 | | Pfizer AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Xeljanz 5 mg | Filmtabletten | Coated tablets (Tofacitinibum 5 mg) | L04AA29 | CI | | 02 | Xeljanz 10 mg | Filmtabletten | Coated tablets (Tofacitinibum 10 mg) | L04AA29 | CI |
|
|
|
